151 related articles for article (PubMed ID: 28483521)
21. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
22. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice.
Van Krieken R; Marway M; Parthasarathy P; Mehta N; Ingram AJ; Gao B; Krepinsky JC
Endocrinology; 2018 Mar; 159(3):1479-1495. PubMed ID: 29420703
[TBL] [Abstract][Full Text] [Related]
24. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
25. Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer.
Mouhid L; Gómez de Cedrón M; García-Carrascosa E; Reglero G; Fornari T; Ramírez de Molina A
PLoS One; 2019; 14(3):e0214294. PubMed ID: 30913248
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells.
Li S; Oh YT; Yue P; Khuri FR; Sun SY
Oncogene; 2016 Feb; 35(5):642-50. PubMed ID: 25893295
[TBL] [Abstract][Full Text] [Related]
27. Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division.
Gholkar AA; Cheung K; Williams KJ; Lo YC; Hamideh SA; Nnebe C; Khuu C; Bensinger SJ; Torres JZ
J Biol Chem; 2016 Aug; 291(33):17001-8. PubMed ID: 27378817
[TBL] [Abstract][Full Text] [Related]
28. Fatostatin ameliorates inflammation without affecting cell viability.
Ma S; Murakami K; Tanaka K; Hashimoto M; Tanaka M; Kitagori K; Akizuki S; Nakashima R; Yoshifuji H; Ohmura K; Morinobu A; Mimori T
FEBS Open Bio; 2022 Mar; 12(3):594-604. PubMed ID: 35015380
[TBL] [Abstract][Full Text] [Related]
29. Conservation of lipid metabolic gene transcriptional regulatory networks in fish and mammals.
Carmona-Antoñanzas G; Tocher DR; Martinez-Rubio L; Leaver MJ
Gene; 2014 Jan; 534(1):1-9. PubMed ID: 24177230
[TBL] [Abstract][Full Text] [Related]
30. The effect of feed restriction on expression of hepatic lipogenic genes in broiler chickens and the function of SREBP1.
Wang PH; Ko YH; Chin HJ; Hsu C; Ding ST; Chen CY
Comp Biochem Physiol B Biochem Mol Biol; 2009 Aug; 153(4):327-31. PubMed ID: 19383549
[TBL] [Abstract][Full Text] [Related]
31. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
[TBL] [Abstract][Full Text] [Related]
32. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Chow WA; Guo S; Valdes-Albini F
Anticancer Drugs; 2006 Sep; 17(8):891-903. PubMed ID: 16940799
[TBL] [Abstract][Full Text] [Related]
33. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.
Hussein D; Mo H
Pancreas; 2009 May; 38(4):e124-36. PubMed ID: 19346993
[TBL] [Abstract][Full Text] [Related]
34. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract][Full Text] [Related]
35. Differences of statin activity in 2D and 3D pancreatic cancer cell cultures.
Paškevičiūtė M; Petrikaitė V
Drug Des Devel Ther; 2017; 11():3273-3280. PubMed ID: 29180851
[TBL] [Abstract][Full Text] [Related]
36. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.
Fang Y; Zhao L; Xiao H; Cook KM; Bai Q; Herrick EJ; Chen X; Qin C; Zhu Z; Wakefield MR; Nicholl MB
Med Oncol; 2017 Feb; 34(2):23. PubMed ID: 28058630
[TBL] [Abstract][Full Text] [Related]
37. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells.
Reigan P; Colucci MA; Siegel D; Chilloux A; Moody CJ; Ross D
Biochemistry; 2007 May; 46(20):5941-50. PubMed ID: 17455910
[TBL] [Abstract][Full Text] [Related]
38. Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma.
Luo SD; Tsai HT; Chiu TJ; Li SH; Hsu YL; Su LJ; Tsai MH; Lee CY; Hsiao CC; Chen CH
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628510
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in genes in the SREBP1 signalling pathway and SCD are associated with milk fatty acid composition in Holstein cattle.
Rincon G; Islas-Trejo A; Castillo AR; Bauman DE; German BJ; Medrano JF
J Dairy Res; 2012 Feb; 79(1):66-75. PubMed ID: 22114848
[TBL] [Abstract][Full Text] [Related]
40. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis.
Lin L; Zheng X; Qiu C; Dongol S; Lv Q; Jiang J; Kong B; Wang C
Oncol Rep; 2014 Dec; 32(6):2831-5. PubMed ID: 25270091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
